Trials / Completed
CompletedNCT05899478
Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures
Prospective, Multi-center, Randomized Controlled Study to Evaluate the Effectiveness and Safety of Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Suzhou Hengruihongyuan Medical Technology Co. LTD · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness and safety of the suture-mediated closure system produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. following endovascular peripheral arterial procedures.
Detailed description
Prospective, multi-center, randomized Comparative study using the Suture-mediated Closure System produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.as an investigational device and the Perclose® ProGlide Suture-Mediated Closure System as a comparator. After going through the confirmation of inclusion/exclusion criteria with signed subjects, they will have a procedure either of the two devices. The subjects should follow designated physician's instructions accurately during the clinical trial period. There are about 4 times evaluations Including screening.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tyknot® Suture-Mediated Closure System | Arterial closure to ensure hemostasis at femoral artery puncture points |
| DEVICE | Perclose® ProGlide Suture-Mediated Closure System | Arterial closure to ensure hemostasis at femoral artery puncture points |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2024-01-01
- Completion
- 2024-04-01
- First posted
- 2023-06-12
- Last updated
- 2025-06-25
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05899478. Inclusion in this directory is not an endorsement.